Meeting
2018 ASCO Annual Meeting
Suboptimal regimens in sequential treatment (ST) with ICT (induction chemotherapy) followed by CCRT (concomitant chemotherapy) in "real life" patients with locally advanced pharyngo-laryngeal squamous-cell carcinoma (LAPLSCC) and prognosis.
Authors
Carmen Orte
Hospital de Barbastro, Huesca, Spain
Carmen Orte , Isabel Pajares Bernad , Eugenia Ortega Izquierdo , Eugenio Vicente Gonzalez , Beatriz Bonaga Serrano , Ramon Terre Falcon , Lucrecia Roque Taveras , Javier Martinez-Trufero
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Local-Regional Disease
Citation
J Clin Oncol 36, 2018 (suppl; abstr 6075)
DOI
10.1200/JCO.2018.36.15_suppl.6075
Abstract #
6075
Poster Bd #
63
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Induction chemotherapy with nanosomal docetaxel lipid suspension (NDLS), cisplatin, and fluorouracil in patients with locally advanced head and neck squamous cell carcinoma.
First Author: Ghanashyam Biswas
Poster
2022 ASCO Annual Meeting
Toripalimab combined with chemoradiotherapy for patients with locally advanced cervical squamous cell carcinoma.
First Author: Dan Ou
Poster
2019 ASCO Annual Meeting
Randomized phase Ⅱ trial of uracil/tegafur and cisplatin versus pemetrexed and cisplatin with concurrent thoracic radiotherapy for locally advanced unresectable stage Ⅲ non-squamous non-small-cell lung cancer: NJLCG1001.
First Author: Kana Watanabe
Poster
2014 ASCO Annual Meeting
Induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy as treatment of unresected locally advanced head and neck cancer squamous cell cancer (HNSCC): A meta-analysis of randomized trials.
First Author: Wilfried Budach